ClinicalTrials.Veeva

Menu

Application for Monitoring and Evaluation of Raynaud's Phenomenon (RaynaudMoni)

Grenoble Alpes University Hospital Center (CHU) logo

Grenoble Alpes University Hospital Center (CHU)

Status

Enrolling

Conditions

Raynaud Phenomenon

Treatments

Other: Smartphone application

Study type

Observational

Funder types

Other

Identifiers

NCT03984422
38RC19.099
2019-A00987-50 (Other Identifier)

Details and patient eligibility

About

To evaluate the feasibility of using a smartphone application for monitoring and evaluation of Raynaud's Phenomenon.

Enrollment

120 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • primary or secondary Raynaud phenomenon clinically diagnosed by a physician
  • Phone compatible with the application (most Android smartphones)
  • Non-opposition of participation in the study
  • Affiliation to the social security scheme or beneficiary of such a scheme

Exclusion criteria

  • Subject under administrative or judicial supervision
  • Subject not speaking and not understanding French

Trial design

120 participants in 1 patient group

Raynaud phenomenon
Description:
Use of smartphone application
Treatment:
Other: Smartphone application

Trial contacts and locations

1

Loading...

Central trial contact

Adeline PARIS, PharmD, PhD; Matthieu Roustit, PharmD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems